首页 › 基金 › Affinity Asset Advisors, LLC › BEAM

Affinity Asset Advisors, LLC 对 BEAM 的持仓历史

BEAM THERAPEUTICS INC · 医疗保健

Affinity Asset Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 BEAM(BEAM THERAPEUTICS INC)450,000 股,市值约 US$11.0M,约占其申报组合的 0.51%,在其申报持仓中市值排名第 44 位。 Affinity Asset Advisors, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)450.00K 股
申报持仓市值$11.00M
组合权重0.51%
首次申报Q3 2026
最近变动新进
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Affinity Asset Advisors, LLC 对 BEAM 的持仓演变

Affinity Asset Advisors, LLC 于 Q3 2026 首次披露 BEAM 持仓:450,000 股(约 US$11.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 450.00K $11.00M 新进

关于 BEAM 与 13F 数据

BEAM(BEAM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 31 只申报持有 BEAM,申报仓位最大的包括:法拉龙资本管理 (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), 方舟投资 (US$288.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BEAM 的基金

查看 BEAM 的全部基金持有人 →

常见问题

How long has Affinity Asset Advisors, LLC held BEAM?

Affinity Asset Advisors, LLC has disclosed BEAM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Affinity Asset Advisors, LLC's current position in BEAM?

As of Q3 2026, Affinity Asset Advisors, LLC holds 450.00K shares of BEAM (BEAM THERAPEUTICS INC), valued at $11.00M, representing 0.51% of its reported portfolio and ranking #44.

Has Affinity Asset Advisors, LLC been buying or selling BEAM?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC newly opened its position in BEAM.

Which other funds hold BEAM?

Other major institutional holders of BEAM include 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., 方舟投资, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.